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Abstract 
Implementing a Screening Pathway for Identifying Patients at Risk for Obstructive   
Sleep Apnea in Primary Care 
Emily Fett 
July 16, 2014 
 
Obstructive sleep apnea (OSA) is emerging as a significant health problem largely 
underrecognized by health care providers in the primary care setting (Pagel, 2008).  The 
intent of this practice innovation project was to change and reduce the variation in 
practice for OSA screening that did not follow what is known about best practices.  In 
this study, a preexperimental one-group pretest-posttest design was carried out to 
evaluate the outcomes associated with implementing an evidence-based screening 
pathway into practice for OSA based on the recommendations set forth in a clinical 
practice guideline recently published by the American Academy of Sleep Medicine 
(Epstein et al., 2009).   
The intervention consisted of providing education and training to primary care 
providers and staff for accurately identifying and screening eligible patients according to 
the pathway.  Those individuals who were identified as having symptoms of OSA were 
referred on for a sleep study.  Comparison data consisted of sleep study referral rates over 
a two month period prior to the intervention and were compared to sleep study referral 
rates over a two month period after the intervention was implemented into practice.  The 
analysis indicates that there is not a statistically significant difference between the two 
groups (X
2 
= 1.091, p = 0.148).  However, among the sub-group of patients identified as 
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eligible for screening through chart review, significantly more patients were referred on 
for a sleep study during the post-intervention period compared to the pre-intervention 
period (X
2
 = 7.815, p = 0.003).  Of the 227 patients identified as eligible for screening 
post-intervention, six were referred on for a sleep study.  This result suggests with 95% 
certainty that the intervention (education and training for the implementation of a 
screening pathway) led to a statistically significant increase in the number of patients 
referred on for a sleep study.  The majority of patients who were categorized as eligible 
for screening were White, male, age 50 years or younger, and indicated for screening due 
to their body mass index (>35 kg/m
2
). 
Results of this study demonstrate a small but clinically significant increase in the 
number of sleep study referrals after the pathway was implemented into practice.  Despite 
the relatively few successful screenings that were performed in this study, there is still a 
need for ongoing screening in the primary care setting due to the increasing prevalence 
and debilitating conditions associated with OSA (Chai-Coetzer et al., 2013a).  High 
patient volumes, time restraints, and neglecting to offer screening to every adult patient 
were identified as the major barriers to successfully implementing this project.  
Continued efforts are needed in educating providers about the importance of screening 
for OSA in the primary care setting.  With the increasing prevalence of OSA, there is 
hope for earlier detection and prompter treatment with the advent of routine screening in 
the primary care setting. 
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Chapter I: Introduction 
 Obstructive sleep apnea (OSA) is a common medical condition that is associated 
with poor quality of life and has been linked to many chronic health problems including 
hypertension, diabetes mellitus, cardiovascular disease, depression, and cognitive 
dysfunction (Broström et al., 2012; Culpepper & Roth, 2009; Epstein et al., 2009; Grover 
et al., 2011; Mold et al., 2011; National Sleep Foundation, 2013; Pagel, 2008; Somers et 
al., 2008).  An estimated 18 million people are living with OSA in the United States, and 
the incidence of OSA is paralleling the increase in obesity making proper screening and 
management vitally important for individuals at risk (Broström et al., 2012; Chai-Coetzer 
et al., 2013b; Culpepper & Roth, 2009; Mold et al., 2011; National Sleep Foundation, 
2013; Pagel, 2008; Young, Peppard, & Gottlieb, 2002).  Concerns that OSA is 
significantly undiagnosed and untreated are confirmed with findings from recent studies 
in the field (Chai-Coetzer, Antic, & McEvoy, 2013a; Doghramji, 2008; Mold et al., 
2011).  Findings from one study suggests over 90% of adult participants who visited a 
primary care provider reported sleep-related symptoms suggestive of OSA, and over one-
third of patients were identified as high-risk for OSA (Mold et al., 2011).  However, 
many patients refrained from discussing these symptoms with the provider, and less than 
one-third of patients had sleep-related symptoms documented in their medical record 
(Mold et al., 2011).   
A uniform approach for OSA screening is lacking as there is no standard of care 
or well-established tools for screening for OSA in the primary care setting (Chai-Coetzer 
et al., 2013a).  The increasing prevalence of OSA strongly supports the need for a 
standardized evidence-based tool that primary care providers can routinely use for 
 12 
screening patients (Chai-Coetzer et al., 2013a).  Primary care providers are in an ideal 
position to screen for OSA as patients often seek care in this setting for initial complaints 
of sleep-related concerns (Chai-Coetzer et al., 2013a; Pagel, 2008).  A systematic 
approach to screening is vitally important for identifying patients at risk.  Individuals who 
do not have a bed partner rely on the comprehensive evaluation by a provider to detect 
the symptoms of OSA (Friedman et al., 2010).  This project focused on providing 
providers and staff with the education and training for implementing a screening pathway 
into practice to identify patients at high risk for OSA in primary care.  A clinical practice 
guideline (CPG) published by the American Academy of Sleep Medicine (AASM) was 
distilled down and incorporated into a pathway that was used in this study (Appendix D) 
(Epstein et al., 2009).  Early screening and diagnosis will likely lead to prompter 
treatment and better health outcomes for individuals living with OSA (Chai-Coetzer et 
al., 2013a; Culpepper & Roth, 2009; Pagel, 2008). 
Diagnosing OSA 
Individuals identified as having sleep-related symptoms or who are identified as 
high-risk for OSA are encouraged to undergo a sleep study to receive a confirmed 
diagnosis from a sleep specialist experienced in interpreting sleep study results .  
Polysomnography (PSG) testing in a sleep laboratory has been the preferred method for 
diagnosing OSA in the past as many sleep specialists believe the clinical environment 
provides a controlled setting for evaluating sleep behaviors in someone identified as 
having symptoms of OSA (Epstein et al., 2009).  However, with the increasing awareness 
of OSA and limited availability of sleep labs and PSG, providers and patients are turning 
to home studies that are performed with the use of portable monitors and sensors capable 
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of detecting and recording respiratory events (Epstein et al., 2009).  Both types of 
objective sleep testing are deemed acceptable, however AASM recommends in-
laboratory PSG for patients with significant health problems or another type of sleep 
disorder (Epstein et al., 2009).  In addition to establishing a diagnosis, objective sleep 
testing also categorizes the severity of a patient’s OSA as mild, moderate, or severe based 
on the number of respiratory events reported per hour of sleep (Epstein et al., 2009).  
Treatment plans can then be individualized according to the severity of the patient’s 
OSA.  Objective sleep testing is not recommended for individuals in the absence of 
identified symptoms or known risk factors (Epstein et al., 2009).   
OSA is diagnosed in patients with a history of “daytime sleepiness, loud snoring, 
witnessed breathing interruptions, or awakenings due to gasping or choking in the 
presence of at least 5 obstructive respiratory events (apneas, hypopneas or respiratory 
effort related arousals) per hour of sleep” detected during objective sleep testing 
according to AASM (Epstein et al., 2009, p. 263).  An OSA diagnosis should also be 
made if a patient denies having OSA symptoms but experiences at least 15 obstructive 
events per hour of sleep during objective sleep testing (Epstein et al., 2009).  OSA differs 
from central sleep apnea that occurs as a result of the brain failing to control breathing 
during sleep (National Sleep Foundation, 2013).   
Systemic Effects of OSA 
Individuals with OSA often experience brief periods of apnea and frequent 
awakenings during sleep as a result of throat muscles that relax and obstruct the airway 
(National Sleep Foundation, 2013).  The reoccurrence of obstructive events during sleep 
leads to decreased oxygen and increased carbon dioxide levels in the body.  Over time, 
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these episodes place significant stress on the body and place the individual at risk for 
developing cardiovascular disease (Kapur, 2010; Somers et al., 2008).  The mechanisms 
by which OSA may play a role in the development and progression of cardiovascular 
disease are shown in Figure 1 (Somers et al., 2008). 
 
Figure 1. “Schematic outlining proposed pathophysiological components of OSA, 
activation of cardiovascular disease mechanisms, and consequent development of 
established cardiovascular disease”. Adapted from “Sleep Apnea and Cardiovascular 
Disease: An American Heart Association/American College of Cardiology Foundation 
Scientific Statement from the American Heart Association Council for High Blood 
Pressure Research Professional Education Committee, Council on Clinical Cardiology, 
Stroke Council, and Council on Cardiovascular Nursing,” by V. Somers, D. White, R. 
Amin, W. Abraham, F. Costa, A. Culebras, . . . T. Young, 2008, Circulation, 118, p. 
1085. Copyright 2008 by American Heart Association, Inc. Reprinted with permission. 
 
Significance of Problem 
 OSA is emerging as a significant health problem largely underrecognized by 
health care providers in the primary care setting (Pagel, 2008).  Results from a survey by 
the National Sleep Foundation, in 2005, indicate that 26% of people living in the United 
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States were at high risk for OSA (Hiestand, Britz, Goldman, & Phillips, 2006).  A 
review of epidemiological data by Young, Peppard, and Gottlieb (2002) determined that 
nearly 1 in 5 adults has mild OSA, and 1 in 15 adults has moderate OSA.  However, the 
true prevalence of this condition is difficult to measure as there is no specific lab test or 
evidence-based metric available for detecting OSA (Kapur, 2010).  Persons of all ages 
are affected by OSA; however males, individuals with certain medical conditions 
including obesity, type II diabetes, and heart failure, and those with a positive family 
history have an increased risk (Culpepper & Roth, 2009; Epstein et al., 2009; Grover et 
al., 2011; Kapur, 2010; Mold et al., 2011; West, Nicoll, & Stradling, 2006).  Limited data 
exists in support of OSA-associated mortality as it is difficult to establish if negative 
outcomes are truly caused from OSA or from other disease processes, especially among 
individuals with underlying cardiovascular disease, obesity, diabetes, or metabolic 
syndrome (Kapur, 2010; Somers et al., 2008).  Familial studies strongly suggest a link 
between OSA and such genetic factors as body fat distribution, craniofacial anatomy, and 
obesity; and those at higher risk include males, older adults, and individuals who are 
obese (Casale et al., 2009; Chai-Coetzer et al., 2013a; Grover et al., 2011; Kapur, 2010; 
Mold et al., 2011; Somers et al., 2008).   
 In a recent study, Chai-Coetzer and colleagues (2013b) evaluated the clinical 
efficacy and cost of diagnosing and treating OSA in primary care centers compared to 
specialty sleep centers.  Outcomes measured at baseline and after 6 months of treatment 
included scores on the Epworth Sleepiness Scale (ESS) and improved health and quality 
of life evaluated with various questionnaires, adherence to continuous positive airway 
pressure (CPAP) therapy, and changes in weight and blood pressure readings (Chai-
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Coetzer et al., 2013b).  Results from this study showed that both groups experienced 
significant improvements in the ESS scores and neither group experienced better health 
outcomes (Chai-Coetzer et al., 2013b).  The authors concluded that better access to 
services and reduced costs associated with the diagnosis and management of OSA may 
result if providers in the primary care setting are motivated, skilled, and committed to 
offering these services to patients, especially those living in rural and underserved areas 
(Chai-Coetzer et al., 2013b).   
 Persons living with undiagnosed or untreated OSA often experience a poor 
quality of life related to excessive daytime sleepiness, decreased vitality, poor social 
functioning, decreased libido, depression, irritability, and other negative health outcomes 
associated with the disease process (Culpepper & Roth, 2009; Kapur, 2010; Pagel, 2008).  
The increasing prevalence of OSA is placing great demand on sleep centers and 
specialists, resulting in long wait times and delayed diagnosis for many individuals 
experiencing OSA or other sleep-related symptoms (Chai-Coetzer et al., 2013b).  Persons 
living in rural communities have limited access to sleep centers and may have to travel 
long distances to seek treatment for a rather uncomplicated condition that could otherwise 
be ideally treated by a primary care provider capable of screening, diagnosing, and 
managing OSA (Chai-Coetzer et al., 2013a; Chai-Coetzer et al., 2013b; Culpepper & 
Roth, 2009; Doghramji, 2008; Grover et al., 2011; Lieberman, 2009; Pagel, 2008; Rakel, 
2009).  Better screening practices in primary care will likely demonstrate a need for more 
diagnostic testing services that are readily accessible to ensure patients receive a 
diagnosis of OSA in a timely manner.  
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 In addition to these concerns, costs associated with management of OSA and 
the consequences that occur as a result of the disease process have a significant economic 
impact on the affected individual as well as society (Kapur, 2010; Pagel, 2008).  In one 
study of 238 patients in the United States, the mean medical cost of medical care per 
patient in the year prior to receiving a diagnosis of OSA was $2,720 as compared to 
$1,384 for controls matched for sex and age (Kapur et al., 1999).   
 In the United States in the year 2000, more than 800,000 drivers, 1,400 deaths, 
and an estimated $15.9 billion in spending were associated with OSA-related motor 
vehicle accidents (Sassani et al., 2004).  A CPG recently published by the American 
Thoracic Society asserts that sleepiness may be a leading factor in “up to 20% of crashes 
on monotonous roads, especially highways” (Strohl et al., 2013, p. 1259).  The CPG also 
declares that OSA “is the most common medical disorder that causes excessive daytime 
sleepiness, increasing the risk for drowsy driving two to three times” (p. 1259).  In 
addition to motor vehicle accidents, individuals experiencing excessive sleepiness or 
cognitive impairment are at risk for work-related accidents and poor job performance, 
especially those who operate machinery or work in a high-stress environment (Culpepper 
& Roth, 2009; Pagel, 2008).   More research is needed to better determine the impact that 
this disorder has on society, the economy, and the health care community at large (Pagel, 
2008).  Routine screening provides the foundation for improving health outcomes and 
abating consequences associated with OSA (Culpepper & Roth, 2009; Epstein et al., 
2009). 
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PICOT Question 
 The formulated clinical question that guided this project is: Among providers and 
staff who care for adult patients in a primary care clinic (P), does the education and 
training for the implementation of a screening pathway for OSA (I) compared to the 
current practice of not using a screening pathway (C) lead to an increase in the number of 
patients referred on for a sleep study by the provider (O) over a period of two months 
(T)? 
Purpose of the Study 
 Health care providers at a primary care clinic in a large rural community in 
southern Minnesota identified a need and were interested in implementing OSA 
screening into practice for adult patients.  Patients were not routinely screened for OSA, 
and providers often neglected to address the issue if the patient, family, or nursing staff 
failed to bring it to the provider’s attention.  The intent of this practice innovation project 
was to change and reduce the variation in practice for OSA screening that did not follow 
what is known about best practices.  This project focused on providing education and 
training to providers and staff for implementing a screening pathway into practice to 
identify adult patients at risk for OSA.  Those who were identified as having symptoms 
of OSA were referred on for a sleep study.   
Patient referral rates served as the proxy for evaluating the outcomes of this study.  
The ultimate goal of the screening was to determine if patients, who were referred for 
objective sleep testing, were actually tested, but this was beyond the scope of the project.  
Comparison data was obtained through a retrospective chart review at the clinical site.  
Extrapolating the providers’ behavior prior to implementation required a review of 
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documentation from patient encounters during a two month period to determine how 
many sleep study referrals were made by the providers in the intervention group.   
Research Questions 
1. What percentage of patients, who met inclusion criteria for the study, were 
appropriately screened for OSA according to the pathway? 
2. Of the patients appropriately screened for OSA, how many were referred on 
for a sleep study by the provider? 
3. How many patients were referred for a sleep study by a provider in the 
intervention group during a two month period prior to implementation of the 
study? 
Definitions 
 Obstructive sleep apnea (OSA): a sleep disorder that is diagnosed if a patient has 
a history of “daytime sleepiness, loud snoring, witnessed breathing interruptions, or 
awakenings due to gasping or choking in the presence of at least 5 obstructive respiratory 
events (apneas, hypopneas or respiratory effort related arousals) per hour of sleep”, or if a 
patient denies having OSA symptoms but experiences at least 15 obstructive events per 
hour of sleep (Epstein et al., 2009, p. 263). 
 Adult: an individual that is 18 years of age or older. 
 Sleep study: the use of biosensors to monitor a patient while sleeping to detect 
episodes of apnea (cessation of breathing) and hypopnea (slow or shallow breathing).  
Sleep studies can be conducted in a sleep laboratory or via portable monitoring in the 
home setting.  Both types of objective sleep testing are deemed acceptable by AASM 
(Epstein et al., 2009). 
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Retrognathia: “malocclusion of the mouth due to an abnormal posterior position 
of the maxilla or mandible” (Gutierrez & Brady, 2013, p. 566).  Patients are evaluated for 
this condition during the screening process. 
Sleep disorder: an encompassing term that refers to any sleep condition defined in 
the International Classification of Sleep Disorders; “most are marked by one of these 
symptoms: excessive daytime sleepiness, difficulty initiating or maintaining sleep, or 
abnormal movements, behaviors, and sensations occurring during sleep” (Institute of 
Medicine, 2006, p. 56). 
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Chapter 2: Review of Literature 
Introduction 
 A review of literature was conducted using the Cochrane Library, National 
Guideline Clearinghouse, EBSCO MegaFILE, CINAHL Plus with Full Text, MEDLINE, 
MasterFILE Premier, Academic Search Premier, and Health Source: Nursing/Academic 
Edition databases to gather data for this critical literature review.  Keywords used in 
searches include obstructive sleep apnea, OSA, and primary care.  These keyword 
searches resulted in 134 citations.  Articles were further limited with the following 
parameters: articles published between 2003 and 2013 and peer reviewed journals.  This 
search produced 112 citations.  Furthermore, 15 studies on children were excluded, 51 
studies focused solely on the treatment of OSA were excluded, and five studies focused 
on a surgical population were excluded.  Abstracts were reviewed from the remaining 41 
citations, ten articles were retrieved and reviewed, and three articles were retained and 
synthesized for this paper.  Two additional articles were discovered after searching the 
reference lists of relevant articles and were also synthesized for this paper (Culpepper & 
Roth, 2009; Grover et al., 2011). 
Current Evidence in Support of OSA Screening 
Screening in primary care. Several research studies and one systematic review 
have evaluated the impact of screening for OSA in primary care as shown in the evidence 
table  (Appendix C) (Broström et al., 2012; Chai-Coetzer et al., 2013b; Culpepper & 
Roth, 2009; Grover et al., 2011; Mold et al., 2011).  Culpepper and Roth (2009) 
systematically reviewed 239 articles to describe the role of the health care provider in 
assessing for OSA in the primary care setting.  This article is appraised as level III 
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evidence as the authors reviewed randomized controlled trials (RCTs), meta-analyses, 
clinical trials, and reviews (Culpepper & Roth, 2009; Dearholt & Dang, 2012).  In this 
article, Culpepper and Roth (2009) discussed the importance of screening patients who 
present with excessive sleepiness, depression, or other comorbid conditions associated 
with OSA to assist patients in receiving proper treatment and experiencing better health 
and quality of life.  Proper screening and management in all settings, including primary 
care, will lead to lower morbidity and mortality rates associated with OSA (Culpepper & 
Roth, 2009; Pagel, 2008). 
A quantitative non-experimental study, appraised as level III evidence, was 
carried out with 249 patients at two primary care sites within the same health care system 
(Dearholt & Dang, 2012; Grover et al., 2011).  The purpose of this study was to evaluate 
the sensitivity of a review of systems (ROS) form for detecting sleep-related complaints, 
determine how often providers investigate these complaints, evaluate the prevalence of 
patients identified as at-risk for OSA, and determine how well patient responses aid in the 
identification of patients as high-risk for OSA (Grover et al., 2011).  Results from this 
study revealed that 37% of participants had positive responses to sleep-related questions 
on the ROS form but physicians had documented only 24% of those symptoms (Grover et 
al., 2011).  A total of 33% of patients had an increased risk of developing OSA and 57% 
of patients identified as high-risk responded positively to an ROS question as compared 
to 27% identified as lower-risk (Grover et al., 2011).  Responses on the ROS form were 
73% specific and 57% sensitive for identifying patients at increased risk for OSA (Grover 
et al., 2011).  The authors concluded that sleep-related symptoms were recognized more 
frequently when physicians used a ROS form (Grover at al., 2011).  However, few 
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complaints from the patients were acknowledged by the provider and the sleep 
questions on the current ROS form were not sensitive enough to identify patients at 
increased risk for OSA (Grover et al., 2011). 
Screening and sleep testing. Chai-Coetzer et al. (2011) developed a model 
consisting of a screening questionnaire and subsequent home sleep study to identify 
patients with OSA in the primary care setting (level III evidence) (Dearholt & Dang, 
2012).  A total of 157 adult patients (ages 25-70 years) receiving primary care services at 
one of six clinics in South Australia participated in this study (Chai-Coetzer et al., 2011).  
The screening questionnaire (OSA50 questionnaire) evaluated witnessed apneas, waist 
circumference, age and snoring as these factors were determined to be highly predictive 
of OSA (Chai-Coetzer et al., 2011).  The monitoring equipment used in the home sleep 
studies was also validated against full PSG and found to be predictive of OSA (Chai-
Coetzer et al., 2011).  Results from this study support the use of this two-stage model to 
appropriately identify individuals with OSA in the primary care setting (Chai-Coetzer et 
al., 2011). 
Broström and colleagues (2012) implemented a study to screen for OSA in adult 
patients diagnosed with hypertension in one of four primary care clinics in Sweden (level 
III evidence) (Dearholt & Dang, 2012).  A total of 411 patients, ages 18-65 years, 
diagnosed and treated for hypertension, were evaluated for OSA with a series of methods 
including clinical assessment, questionnaires, and a full-night sleep study  (Broström et 
al., 2012).  Results indicated that 29% of the patients had mild OSA and 30% of the 
patients had moderate/severe OSA (Broström et al., 2012).  Obesity was also present in 
30% of the patients with mild OSA and 68% of the patients with moderate/severe OSA 
 24 
(Broström et al., 2012).  In this study, the authors discovered that undiagnosed OSA is 
common in patients with a history of hypertension, and in addition to obesity, male 
gender, snoring, long sleep duration, and witnessed apneas were the most reliable 
predictors of OSA (Broström et al., 2012). 
Clinical practice guideline. A CPG, appraised as level IV evidence, was released 
in 2009 by the Adult Obstructive Sleep Apnea Task Force of the AASM to provide health 
care providers with a general overview on the diagnosis, management and treatment of 
OSA in adults (Dearholt & Dang, 2012; Epstein et al., 2009).  The guideline recommends 
OSA screening for all patients during routine health maintenance exams and for patients 
who complain of OSA symptoms or are identified as high risk for OSA in the primary 
care setting (Epstein et al., 2009).  An algorithm is provided to assist providers in 
screening, diagnosing, and treating individuals identified as high-risk for OSA.  The 
focus of OSA as a chronic disease is emphasized in this article to make providers aware 
of the need for lifelong, multidisciplinary management for individuals diagnosed with 
this disorder (Epstein et al., 2009).  The intended goal of proper risk identification, 
diagnosis, and management is to reduce complications associated with OSA, namely 
cardiovascular disease (Epstein et al., 2009). 
Gaps in the Evidence 
 A current gap identified from the review of literature includes the availability and 
application of specific tools and precise guidelines for primary care providers to use in 
identifying individuals at high risk for OSA who may greatly benefit from undergoing 
further testing (Chai-Coetzer et al., 2011; Mold et al., 2011).  The Berlin and STOP-Bang 
questionnaires, ESS, Mallampati score (evaluation of oropharynx to determine ease of 
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intubation and risk of sleep apnea), review of systems, and measurement of truncal 
obesity are some of the tools and methods used by providers to screen for OSA, however 
no particular method has been found  to be specific enough to diagnose the condition 
(Chai-Coetzer et al., 2011; Chai-Coetzer et al., 2013a; Friedman et al., 2010; Grover et 
al., 2011; Jacobs & Coffey, 2009; Nuckton, Glidden, Browner, & Claman, 2006; Vana, 
Silva, & Goldberg, 2013).  Questionnaires and screening tools do however assist 
providers in identifying patients at risk who may benefit from undergoing further 
diagnostic testing for OSA or other sleep disorders (Chai-Coetzer et al., 2013a).  Studies 
evaluating the validity and reliability of screening tools often focus on the surgical 
population as OSA is a significant concern for individuals requiring general anesthesia 
and sedation for surgery (Abrishami, Khajehdehi, & Chung; 2010; Sundar, Chang, & 
Smetana, 2011).  Limited data exists in support of the best practices for screening in the 
primary care setting (Chai-Coetzer et al., 2011).  
Friedman and colleagues (2010) published a study with promising findings to 
support the use of multiple instruments in accurately screening and diagnosing patients 
with OSA, however the proposed algorithm is fairly complex and is more appropriate for 
use in the specialty setting rather than the primary care setting.  Furthermore, the findings 
from this study cannot be generalized to the population at large due to the relatively small 
sample size of 223 patients.   
A substantial body of research has recently focused on the development and 
validation of ambulatory models of care for the diagnosis (portable sleep monitoring at 
home versus PSG testing at a sleep center) and management (auto-titrating CPAP in the 
home versus CPAP therapy managed by a sleep specialist) of OSA rather than on the 
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screening process itself for individuals not yet diagnosed with the condition (Antic et 
al., 2009; Berry, Hill, Thompson, & McLaurin, 2008; Chai-Coetzer et al., 2013a; Chai-
Coetzer et al., 2013b; Kuna et al., 2011; Mulgrew, Fox, Ayas, & Ryan, 2007; Rosen et 
al., 2012).  Individuals need to be appropriately screened before diagnosis and 
management can occur.  Chai-Coetzer et al. (2011) note that “suitably simple, accurate 
and validated strategies capturing both symptomatology and objective signs of overnight 
breathing disturbances are needed” (p. 213-214).  The CPG released by the AASM 
provides consensus-based recommendations based on expert opinion rather than 
empirically-based recommendations supported by sound research (Epstein et al., 2009).   
It is evident from this critical review of literature that additional research is 
needed to support a systematic approach and provide clinicians with clearer guidelines 
for screening for OSA in the primary care setting (Chai-Coetzer et al., 2011; Mold et al., 
2011).  Providers are in need of a valid and reliable screening pathway that can be 
incorporated into practice to appropriately identify patients at risk for OSA.  A pathway 
that is valid, reliable, and simple to use will likely lead to provider and staff satisfaction 
and adherence to its use in the clinical setting. 
Model of Evidence-Based Care 
Johns Hopkins Nursing Evidence-Based Practice Model.  The Johns Hopkins 
Nursing Evidence-Based Practice (JHNEBP) Model illustrates the key factors and 
components that are considered to be foundational for evidence-based practice (EBP) in 
nursing (Dearholt & Dang, 2012; Figure 2).  The Model is depicted as an open-system 
with internal and external factors influencing practice, education, and research (Dearholt 
& Dang, 2012).  At the center of the Model is evidence, consisting of data from sources 
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that are both research and non-research-based (Dearholt & Dang, 2012).  Health care 
professionals are encouraged to implement guidelines based on the most current 
knowledge available to them, while also considering the individual needs of the patient 
and the barriers that may exist in the practice setting.  Creating transformational change 
within a health care system commands support from stakeholders and employees who 
value the implementation of evidence-based recommendations into practice.  Results 
from this project add support to the current state of the science for screening of 
individuals with OSA. 
Figure 2. JHNEBP Model. Adapted from  Johns Hopkins Nursing Evidence-Based 
Practice: Model and Guidelines, by S. L. Dearholt & D. Dang (Eds.), 2012, 2nd ed., p. 
34. Copyright 2013 by The Johns Hopkins Hospital/The Johns Hopkins University. 
Reprinted with permission. 
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JHNEBP PET Process.  The JHNEBP PET process provides the necessary 
framework for creating evidence-based change within an organization.  The stepwise 
approach consists of 18 steps that carry an individual or team through the stages of 
developing a practice question, gathering supportive evidence, and translating findings 
into practice (Dearholt & Dang, 2012; Figure 3).  For this project, a team of health care 
providers and staff participated in the development and refinement of the EBP (PICOT) 
question.  A thorough review of literature was performed to identify the current state of 
the science regarding OSA screening in primary care, and gaps in the evidence that exist 
at this time.  Recommendations were incorporated into an action plan and approval was 
sought from the stakeholder and team members prior to implementation of this project. 
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Figure 3. JHNEBP PET Process. Adapted from  Johns Hopkins Nursing Evidence-Based 
Practice: Model and Guidelines, by S. L. Dearholt & D. Dang (Eds.), 2012, 2nd ed., p. 
236. Copyright 2013 by The Johns Hopkins Hospital/The Johns Hopkins University. 
Reprinted with permission. 
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Conceptual Framework 
 The Chronic Care Model.  The Chronic Care Model (CCM) provides the 
structural framework for the treatment and management of chronic illness.  When 
operationalized, the model creates a therapeutic environment for the productive 
interaction between motivated patients and expert care providers (Watts et al., 2009).  
The goal of the model is to improve patient outcomes and provider satisfaction, and 
reduce costs associated with chronic illness care (Improving Chronic Illness Care, 2010).  
Health system and community.  The CCM consists of six elements that are 
essential for a health care system to operate effectively and provide quality patient care: 
delivery system design, decision support, clinical information systems, self-management 
support, resources and policies, and organization of health care (Figure 4).  The CCM 
guided the development of this project that focused on screening individuals for OSA in 
the primary care setting. 
Patient data was collected during the patient encounter by health care providers 
and staff involved in the study.  The electronic health record was accessed by the 
principal investigator to identify those who were eligible for screening, as well as those 
who received sleep study referrals before and after the pathway was implemented into 
practice.  Results from this project were further evaluated by the principal investigator 
upon completion of the study.  Providers and staff remained informed throughout the 
duration of the study through the use of open communication from the principal 
investigator.  Cooperative patients and a coordinated health care team were crucial for 
ensuring screening was performed according to the pathway (Appendix D). 
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Productive interactions and relationships.   Productive interactions between 
the patient and care team are essential for the development and maintenance of patient-
centered care.  One of the goals of this project was to create a trusting and productive 
relationship between the patient and provider that allowed for open and honest 
communication at all times, especially when sharing personal health information.  
Productive interactions are likely to occur when the patient and family feel informed and 
empowered, and the provider is prepared to offer evidence-based recommendations for 
treatment (Watts et al., 2009).  Patients who are identified as having symptoms of OSA 
must be motivated to seek testing and treatment to decrease the likelihood of 
experiencing negative health outcomes associated with OSA.  Early detection and 
treatment of OSA by primary care providers will likely lead to patients receiving 
appropriate therapy and follow-up, as well as to cost savings for the health care system. 
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Figure 4. The Chronic Care Model. Adapted from “Chronic Disease Management: What 
Will It Take to Improve Care for Chronic Illness?” by E. H. Wagner, 1998, Effective 
Clinical Practice, 1, p. 3. Copyright 1998 by American College of Physicians-American 
Society of Internal Medicine. Reprinted with permission. 
 
 
Change Theory  
 Plan-Do-Study-Act cycle.  The Plan-Do-Study-Act (PDSA) cycle provides a 
framework and approach for developing and implementing effective change at an 
organizational level (Levin, 2009).  The Plan phase requires the team to develop 
objectives, make predictions about outcomes, and create a plan for implementing a small 
test of change (Levin, 2009).  In the Do phase, the plan is carried out and data is collected 
(Levin, 2009).  Observations are also made to determine what did and did not go well 
during implementation of the small test of change (Levin, 2009).  A thorough evaluation 
of the data collected in the second phase occurs in the Study phase (Levin, 2009).  In 
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addition, the results are summarized and compared to the predictions or anticipated 
outcomes from the Plan phase (Levin, 2009).  Lastly, the Act phase occurs when team 
members determine whether or not the results are favorable and decide on what changes 
need to be made before beginning the next PDSA cycle (Levin, 2009).   
System-wide change becomes possible when multiple cycles have produced 
promising results.  The PDSA cycle provided an evidence-based approach for 
implementing this project as a pilot test in a large rural primary care practice.  Results 
from this study can be reflected on to determine how to proceed with future projects 
focused on OSA screening in primary care.  The PDSA cycle is depicted in Figure 5. 
 
 
Figure 5. PDSA Cycle. Available on www.IHI.org. Copyright 2013 by Institute for 
Health care Improvement. Reprinted with permission. 
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Chapter 3: Project Design and Methodology 
Study Design 
 A preexperimental study with a one-group pretest-posttest design was carried out 
to evaluate the outcomes associated with implementing a screening pathway into practice 
for OSA.  The intervention consisted of providing education and training to primary care 
providers and staff for accurately identifying and screening eligible patients according to 
the pathway (Appendix D).  This chapter will discuss the sample, setting, and 
methodology of the study.  The intervention, instruments, context, and analysis will also 
be reviewed. 
Sample/Population 
The population for this study consisted of the providers and staff at a primary care 
clinic located in a large rural community in southern Minnesota.  The intervention group 
included the providers and staff who participated in the screening process of eligible 
patients by following the pathway (Appendix D).  Patients who were identified as having 
symptoms of OSA were referred on for a sleep study.  In addition to the two primary care 
providers, those involved with this study included reception and clinical nursing staff.  
The study took place over a period of approximately two months.  There were no 
exclusion criteria identified as all providers and staff had agreed to participate in this 
study.  Comparison data were obtained through a retrospective chart review at the clinical 
site.  Extrapolating the providers’ behavior prior to implementation required review of 
documentation from patient encounters during a two month period to determine how 
many sleep study referrals were made by the providers in the intervention group.    
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Environmental and Organizational Context 
 Prior to the commencement of the study, there was no standardized process for 
OSA screening at the clinic.  The key stakeholder, additional provider, and staff were all 
in support of this project.  Staff were notified of the project’s timeline and were kept 
informed of any changes as they were made during the planning process.  The clinic was 
equipped with the appropriate supplies and information needed for successfully 
implementing this project. 
Study Intervention and Integration of Evidence 
 Prior to commencement of the study, providers and staff met one-on-one with the 
principal investigator to discuss the process that is outlined in the screening pathway 
(Appendix D).  Additional education on OSA and the importance of screening was 
provided to staff on an individualized basis depending on each person’s familiarity with 
the condition.  Expectations for the project were provided and concerns were addressed 
before the study began.  As is recommended to consider in the Plan phase of the PDSA 
cycle, minor changes were made to the screening forms based on provider and staff 
feedback obtained during the educational sessions to enhance usability of the forms 
(Levin, 2009).    
The screening recommendations set forth by AASM’s CPG were implemented 
into a pathway that was used with adult patients who were identified as eligible for 
screening (Epstein et al., 2009).  The following information was provided to staff to 
ensure a standardized process was followed throughout the duration of the study: 
1.  Staff were expected to follow the screening pathway to ensure all steps of the process 
were carried out in a systematic way for eligible patients (Appendix D). 
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2. Reception staff were asked to distribute a screening packet to every patient who was 
18 years of age or older and English-speaking at the time of check-in.  Adult patients who 
presented for routine health maintenance exams, were being evaluated for symptoms of 
OSA (Table 1), or who were identified at high-risk, who did not already have a 
confirmed diagnosis of sleep apnea, were screened (Appendix E) (Epstein et al., 2009).  
Instructions for filling out Form A, the ESS, and Form B were highlighted to direct the 
patient in completing the initial steps of the screening process while he/she was waiting 
to be seen by the provider (Appendices E, F, & G).   
3. Nursing staff were asked to measure the patient’s height, weight, and body mass index, 
and complete the remaining questions on Form B (Appendix G).  A comprehensive sleep 
evaluation (Appendix H) by a provider was indicated if the patient had answered 
positively to one or more of the questions on Form B (Appendix G).  The study 
concluded for those patients who did not have symptoms of a sleep disorder as indicated 
by a positive response on Form B (Appendix G).  
4. Providers were asked to make a recommendation for a sleep study for any patient 
whom they felt had symptoms of OSA (Table 1).  In addition, providers were asked to 
identify a level of risk for each patient in whom a sleep study was recommended 
(Appendix H).  The level of risk was determined by findings from the history and 
physical exam. 
5. Patients referred on for a sleep study received an educational pamphlet on OSA from 
AASM and contact information for setting up a sleep study.      
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Table 1 
OSA Symptoms 
Witnessed apneas (episodes of stopping breathing during sleep) 
Snoring 
Gasping or choking at night 
Memory loss 
Decreased concentration 
Decreased libido (sexual desire) 
Irritability 
Depression 
Morning headaches 
Nocturia (waking up from sleep to urinate) 
Nonrefreshing sleep 
Concerns with total sleep amount 
Insomnia or sleep fragmentation (frequent awakenings) 
Excessive sleepiness not explained by other factors  
 
 
Facilitators and Barriers to the Project 
 
 Facilitators.  A key stakeholder for this project was a provider who worked at the 
primary care clinic where the study took place.  The success of this project was 
dependent on staff and provider adherence to the screening process.  Guidance and 
support were welcomed from a project advisor and committee from the Department of 
Graduate Nursing at South Dakota State University.  Additional facilitators for 
implementation of the project included dissemination of evidence in support of this 
project prior to implementation, excitement and motivation from the providers and staff, 
and the diffusion of positive messages about this study in the community.            
 Barriers. Barriers were identified during the planning phase that may have led to 
resistance, discouragement, or less-than-ideal outcomes throughout the study.  
Uninterested patients, inadequate training and education for staff, and incomplete or 
inaccurate documentation on screening forms were identified as potential barriers to the 
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successful completion of this project.  Concerns were addressed in a timely manner in 
an attempt to avoid opposition from providers, staff, and patients. 
Impact on Health Care for the Rural and Underserved Populations 
Prompter treatment and better health outcomes are likely to result from the early 
detection and diagnosis of OSA in the primary care setting (Chai-Coetzer et al., 2013a; 
Culpepper & Roth, 2009; Pagel, 2008).  This statement is especially true for the rural and 
underserved populations that often have poor access to specialty care.  In addition to 
being located in large cities that may require patients to travel long distances for care, 
specialty care centers often have full schedules and patients may have to wait for weeks 
or months to see a sleep specialist (Chai-Coetzer et al., 2013a; Chai-Coetzer et al., 
2013b).  The rising costs of specialty care also pose a barrier to individuals experiencing 
socioeconomic hardships (Chai-Coetzer et al., 2013a).  Performing OSA screening in 
primary care will likely increase patient and family satisfaction with care, improve 
quality of life for patients living with OSA, improve treatment of comorbid conditions 
associated with OSA including depression, diabetes, and hypertension, reduce morbidity 
and mortality associated with OSA, and create cost savings for both the patient and the 
health care system (Culpepper & Roth, 2009; Epstein et al., 2009; Lieberman, 2009; 
Pagel, 2008; Rakel, 2009).  A reduction in motor vehicle and occupational accidents may 
also occur as more individuals with excessive daytime sleepiness are identified, 
diagnosed, and treated for OSA (Grover et al., 2011; Pagel, 2008, Rakel, 2009).   
Protection of Human Subjects 
Approval for implementing this project was obtained from the medical director at 
the clinical site and the Human Subjects Committee at South Dakota State University 
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(Appendices A & B).  Patients had the right to refuse screening at any time without 
reprimand.  Data collected during the study was reviewed and secured by the principle 
investigator in accordance with the regulations set forth in the Health Insurance 
Portability and Accountability Act (United States Department of Health & Human 
Services, 2003). 
Instruments 
The recommendations outlined in AASM’s CPG support the use of one 
instrument in the screening process: the ESS (Appendix F) (Epstein et al., 2009).  The 
main OSA symptom, excessive sleepiness unexplained by other causes, can be evaluated 
with the ESS (Johns, 2000).  A score of 8 or greater may suggest a sleep disorder and 
should be further evaluated by a provider (Rosenthal & Dolan, 2008).  This 
recommendation comes from a study by Rosenthal and Dolan (2008) that retrospectively 
reviewed 268 charts of patients who had filled out the ESS, had been clinically assessed 
by a sleep specialist, and had been diagnosed with OSA after having undergone PSG 
testing.  With a cutoff score of 8, the ESS had shown to have a sensitivity of 76% and 
specificity of 31% in the positive identification of a diagnosis of OSA (Rosenthal & 
Dolan, 2008).  The sensitivity and specificity results associated with other cutoff scores 
were not as optimal as the aforementioned results (Rosenthal & Dolan, 2008).   
The ESS has been shown to have good reliability and internal consistency 
(Gander, Marshall, Harris, & Reid, 2005; Johns, n.d.; Johns, 2002; Ning-Hung Chen et 
al., 2002).  However, a more recent review of literature on the efficacy of the ESS 
indicates that out of 16 studies meeting inclusion criteria, five established a significant 
relationship between the ESS and OSA and 11 failed to establish a significant 
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relationship (Sil & Barr, 2012).  Providers must remember that the ESS only measures 
daytime sleepiness and therefore should not be used as the only tool in assessing for or 
diagnosing OSA (Jacobs & Coffey, 2009; Rosenthal & Dolan, 2008).  Despite the 
conflicting evidence in support of the ESS, the CPG recommends its use in the screening 
process (Epstein et al., 2009).  The ESS is not intended to predict or diagnose OSA but 
rather add one factor in support of ordering a sleep study for an individual with OSA 
symptoms (Epstein et al., 2009; Johns, n.d.). 
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Chapter 4: Outcomes & Impact of Practice Innovation Project 
Data was collected and analyzed by the principle investigator while the study was 
in progress.  The electronic health record of every adult patient being seen by one of the 
providers in the study was reviewed to determine how many sleep study referrals were 
made during the pre and post-intervention phases.  Additionally, every adult encounter 
during the post-intervention phase was reviewed to determine if the patient was eligible 
for OSA screening based on the criteria listed on Form A (Appendix E).  Statistical 
analyses were performed with the assistance of an associate professor of biostatistics at 
South Dakota State University to evaluate the outcomes of this project.  Additional 
demographic analyses were also performed to evaluate the characteristics of age, race, 
sex, and indication for screening in patients identified as eligible for screening during the 
post-implementation phase of this study. 
Discussion of Outcomes 
 A chi-square test of independence was performed to determine if a significant 
difference in sleep study referral rates existed between the pre and post-intervention 
groups.  Comparison data consisted of sleep study referral rates over a two month period 
prior to the intervention and were compared to sleep study referral rates over a two month 
period after the intervention was implemented into practice.  The analysis indicates that 
there is not a statistically significant difference between the two groups (X
2 
= 1.091, p = 
0.148).  The data that was analyzed is shown in Table 2.  However, among the sub-group 
of patients identified as eligible for screening through chart review, significantly more 
were referred on for a sleep study during the post-intervention period compared to the 
pre-intervention period (X
2
 = 7.815, p = 0.003).  Of the 227 patients identified as eligible 
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for screening post-intervention, six were referred on for a sleep study.  This result 
suggests with 95% certainty that the intervention (education and training for the 
implementation of a screening pathway) led to a statistically significant increase in the 
number of patients referred on for a sleep study.  However, the chi-square 
approximations may be of limited value due to the sparsity of data in this study.  After 
reviewing data at the end of the study, the principle investigator noted that patient 
refusals were not recorded and therefore, a complete analysis of data to determine the 
exact number of missed screenings cannot be performed for this study.    
 
Table 2 
Number of Sleep Study Referrals 
 Referred for          
Sleep Study 
Not Referred for           
Sleep Study 
Pre-Intervention 2 
 
653 
Post-Intervention 6 658 
 
Answers to Research Questions 
Results indicate that screening was initiated for 9.7% of eligible patients but was 
only completed for 3.5% of patients.  Of the eight patients appropriately screened for 
OSA, five patients were referred on for a sleep study by the provider.  A total of six sleep 
studies are noted in the post-intervention group due to a patient receiving a referral who 
was not screened (Table 2).  Prior to implementation of the pathway, only 2 patients were 
referred on for a sleep study by a provider in the intervention group.  Seven of the 205 
patients who were identified as eligible for screening by the investigator during chart 
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review responded negatively to all of the questions on the initial screening form and 
were therefore identified by staff as not being eligible for screening.  Demographic data 
is displayed for patients who were identified as eligible for screening according to the 
pathway.  The majority of patients who were categorized as eligible for screening were 
White, male, age 50 years or younger, and indicated for screening due to their body mass 
index (>35 kg/m
2
). 
 
 
Figure 6. Age ranges of patients identified as eligible for OSA screening. 
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      Figure 7. Sex of patients identified as eligible for OSA screening. 
 
 
 
 
 
 
 
 
       Figure 8. Race of patients identified as eligible for OSA screening. N=227 patients. 
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Other Pacific 
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     Figure 9. Indication for OSA screening. 
 
Impact of Project on Patient Care 
An ongoing need for screening in the primary care setting exists due to the 
increasing prevalence and debilitating conditions associated with OSA (Chai-Coetzer et 
al., 2013a).  Results of this study demonstrate a small but clinically significant increase in 
the number of sleep study referrals after the pathway was implemented into practice.  
Despite the relatively few successful screenings that were performed in this study, 
significantly more patients, who were identified as eligible for screening through chart 
review, were referred on for a sleep study during the post-intervention period compared 
to the pre-intervention period.  Of the 22 patients in the post-intervention group who were 
screened according to the pathway, nearly 23% were referred on for a sleep study.  Over 
34% of adult patients visiting the clinic post-implementation of the pathway were 
identified as eligible for screening based on data reviewed in the electronic health record.  
Indication for Screening 
Body Mass Index > 35
Type 2 Diabetes Mellitus
Atrial Fibrillation
Yearly Physical
Stroke
Insomnia
Commercial Truck Driver
Depression
Other
More than 1 Indication
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This figure is consistent with data that suggests 26% to 32% of patients in the primary 
care setting have OSA (Hiestand et al., 2006; Netzer et al., 2003).  Approximately 46% of 
patients were identified as eligible for screening based on their body mass index (>35 
kg/m
2
) and 18% of patients had more than one indication for screening.  It is evident 
from these findings that there is a need for routine screening in this setting. 
High patient volumes, time restraints, and neglecting to offer screening to every 
adult patient were identified as the major barriers to successfully implementing this 
project.  Additionally, the providers and staff noted that screening forms were often set 
aside or overlooked as much of the visit is spent reviewing and documenting patient 
information in the electronic health record instead of on paper.  The majority of patient 
visits were limited to fifteen minute time slots leaving very little time to address OSA 
screening in addition to addressing the patient’s primary health concerns.  Two 
screenings were not completed due to the nature of the patient’s visit as documented by 
the provider on the comprehensive sleep evaluation (Appendix H). 
The Hawthorne Effect was observed at the beginning of the study.  During the 
middle of the study, there was a period of two and a half weeks when additional staff 
were assigned to work in the reception area while the business office was under 
construction due to unforeseen circumstances.  Unfortunately, many patients who were 
seen at the clinic during this time were not offered screening because the business staff 
were not informed about the project.  Despite these challenges, the principal investigator 
made multiple attempts to encourage participation throughout the duration of the study by 
connecting with providers and staff on-site and offering small monetary incentives to all 
who were involved in helping implement this study.   
 47 
Chapter 5: Summary 
Conclusion 
 The direct and indirect costs associated with OSA are placing great demand on 
our nation’s health care system and these costs are expected to rise as the prevalence of 
OSA is paralleling the increase in obesity rates (Broström et al., 2012; Chai-Coetzer et 
al., 2013b; Culpepper & Roth, 2009; Mold et al., 2011; National Sleep Foundation, 2013; 
Pagel, 2008; Young, Peppard, & Gottlieb, 2002).  Many individuals remain undiagnosed 
and untreated despite efforts to increase providers’ awareness about the condition and the 
importance of early screening and detection.  Primary care providers are in a favorable 
position to screen individuals of all ages, especially those who present with sleep-related 
complaints or who have symptoms of OSA.  Continued efforts are needed in educating 
providers about the importance of screening in this setting.  AASM’s CPG provides an 
algorithm for providers to follow to ensure individuals who meet criteria for screening 
are evaluated in a comprehensive manner (Epstein et al., 2009).  Cost-savings and 
improved health outcomes are likely to occur as a result of early diagnosis and treatment 
of individuals with OSA. 
Reflections on the Practice Innovation Project 
 The lessons learned before, during, and after the implementation of this project 
can be reflected on and shared with others who may be interested in pursuing a similar 
quest.  The initial plan for educating and training the staff and providers was to facilitate 
a group session for all participants at the clinic.  Due to the complexity of staff schedules, 
the medical director requested that all education and training be performed on an 
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individual basis.  Due to the limited time available for implementation of the project, 
the decision was made to proceed with the medical director’s request. 
Upon completion of a study, the PDSA cycle guides a researcher in determining 
what went well during implementation, and what needs to be changed before starting the 
next phase of the cycle (Levin 2009).  In considering changes that may be most-effective 
in improving outcomes of this study, one particular idea comes to mind.  Creating a 
template for screening within the electronic health record would likely decrease the time 
it takes to perform the screening, and reduce the number of incomplete screens due to the 
forms being set aside during the visit.  Furthermore, keeping patient data in one location 
(i.e. the electronic health record) is beneficial for the future tracking and reviewing of 
patient data.  Some individuals are not aware of their body mass index and this value 
would be available in the electronic health record for review by staff to determine if the 
patient is eligible for screening.  The ESS would still need to be distributed at check-in as 
this information helps in identifying patients with excessive sleepiness, which is one of 
the symptoms of OSA. 
One of the indications for screening is the presence of resistant hypertension or 
high blood pressure that is hard to treat (Appendix E).  This indication is hard to discern 
with patients who are non-adherent to treatment recommendations or who rarely access 
health care services.  Furthermore, there is not a test to determine if a patient’s high blood 
pressure has been or will be difficult to treat.  Providers need to make an informed 
decision on whether or not a patient should be evaluated for sleep apnea due to the 
concern that long-standing poorly-controlled high blood pressure places an individual at 
risk for serious cardiovascular complications (Somers et al., 2008).  Treating OSA in 
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individuals with a history of resistant hypertension may prove to be more successful 
than pharmacologic therapy alone. 
Implications for Research 
 Continued research is needed to determine the best evidence-based approach for 
OSA screening in primary care.  Determining if primary care providers and other health 
care professionals including nursing staff are capable of diagnosing and managing OSA 
without supervision from a sleep specialist is vital for improving patient care and creating 
cost-savings for the patient and the health care system (Chai-Coetzer et al., 2013a; Chai-
Coetzer et al., 2013b).  Previous studies have shown that ambulatory models of care are 
not clinically inferior to specialty models of care for patients with OSA, however more 
studies are needed that compare the indirect and direct costs of ambulatory care versus 
specialty care (Chai-Coetzer et al., 2013a; Kuna et al., 2011).  Most importantly, more 
research is needed in finding a method of screening that can be utilized by all providers 
that has a high pre-test probability of diagnosing OSA to reduce the likelihood of patients 
having a negative work- up (Kuna, 2010).   
Recommendations for Future Practice 
Further research is needed in the clinical setting to develop a better understanding 
of how providers and staff can implement OSA screening that is feasible and cost-
effective given the barriers of time and high patient volumes that are often present in 
primary care.  Advocating for better reimbursement of OSA management in this setting 
will also help to improve access to care and reduce costs for those individuals who are 
uninsured and underinsured, as well as for those living in rural and underserved areas.  In 
regards to current reimbursement for OSA screening in primary care, providers are only 
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allowed to adjust  the evaluation and management coding for a patient visit if the 
screening performed justifies charging at a higher level of service (C. Winter-Rosenberg, 
personal communication, June 10, 2014).   
Providers have the opportunity to create positive change within an evolving health 
care system by advocating for policy change and demonstrating a commitment to 
providing evidence-based care.  Despite the increasing prevalence of OSA, there is hope 
for earlier detection and prompter treatment with the advent of routine screening in the 
primary care setting.  Cost savings, improved chronic illness management, and a 
reduction in morbidity and mortality associated with OSA will likely result from the early 
diagnosis and proper treatment of this sleep disorder (Culpepper & Roth, 2009; Giles et 
al., 2006; Pagel, 2008). 
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Appendix C: Evidence Table 
Evidence in Support of OSA Screening in Primary Care 
Source Level of 
Evidence 
Purpose Design Sample/ 
Setting 
Results 
Broström 
et al., 
2012 
III To identify the 
causes of 
moderate/sev-
ere OSA and 
describe the 
incidence of 
undiagnosed 
OSA in adult 
patients < 65 
years with 
hypertension. 
Non-
experimental 
quantitative 
study with 
cross-
sectional 
design. 
411 
patients 
participated 
at one of 
four 
primary 
care clinics 
in Sweden. 
29% of patients had 
mild OSA and 30% of 
the patients had 
moderate/severe OSA.  
Obesity was present in 
30% of the patients 
with mild OSA and 
68% of the patients 
with moderate/severe 
OSA.  In addition to 
obesity, male gender, 
snoring, long sleep 
duration, and witnessed 
apneas were the most 
reliable predictors of 
OSA. 
Chai-
Coetzer et 
al., 2011 
III To evaluate the 
accuracy of a 
model in 
identifying 
patients with 
OSA.  The 
two-staged 
model 
consisted of a 
screening 
questionnaire 
and subsequent 
home sleep 
study. 
Non-
experimental 
quantitative 
study with 
predictive 
design. 
157 
patients 
participated 
who 
received 
primary 
care 
services at 
one of six 
clinics in 
South 
Australia. 
Results from this study 
support the use of this 
two-stage model to 
appropriately identify 
individuals with OSA 
in the primary care 
setting. 
Culpepper 
& Roth, 
2009 
III To describe the 
role of the 
health care 
provider in 
assessing for 
OSA in the 
primary care 
setting. 
Systematic 
review 
239 articles 
included in 
review 
Primary care providers 
have a pivotal role in 
identifying OSA in 
patients presenting with 
risk factors or comorbid 
conditions including 
depression, 
hypertension, and 
diabetes. 
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Epstein et 
al., 2009  
IV To provide 
health care 
providers with 
a general 
overview on 
the diagnosis, 
management 
and treatment 
of OSA in 
adults. 
Clinical 
practice 
guideline 
None An algorithm is 
provided to assist 
providers in screening, 
diagnosing, and treating 
individuals identified as 
high-risk for OSA.  
Screening in the 
primary care setting is 
recommended for all 
patients during routine 
health maintenance 
exams and for patients 
who complain of OSA 
symptoms or are 
identified as high risk 
for OSA. 
Grover et 
al., 2011 
III To evaluate the 
sensitivity of a 
review of 
systems (ROS) 
form for 
detecting 
sleep-related 
complaints, 
determine how 
often providers 
investigate 
these 
complaints, 
evaluate the 
prevalence of 
patients 
identified as at-
risk for OSA, 
and determine 
how well 
patient 
responses aid 
in the 
identification 
of patients as 
high-risk for 
OSA. 
Non-
experimental, 
quantitative 
study with 
prospective 
design. 
249 of 382 
eligible 
patients 
participated 
at 2 
primary 
care sites 
within the 
same 
health care 
system. 
37% of participants had 
positive responses to 
sleep-related questions 
on the ROS form with 
physicians documenting 
24% of those 
symptoms.  33% of 
patients had an 
increased risk of 
developing OSA. 
Responses on ROS 
form were 73% specific 
and 57% sensitive for 
identifying patients at 
increased risk for OSA.  
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Appendix F: Epworth Sleepiness Scale 
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